Your browser doesn't support javascript.
loading
Vemurafenib acts as a molecular on-off switch governing systemic inflammation in Langerhans cell histiocytosis.
Eder, Sebastian K; Schwentner, Raphaela; Ben Soussia, Philipp; Abagnale, Giulio; Attarbaschi, Andishe; Minkov, Milen; Halbritter, Florian; Hutter, Caroline.
Afiliação
  • Eder SK; St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
  • Schwentner R; St. Anna Children's Cancer Research Institute, Vienna, Austria; and.
  • Ben Soussia P; St. Anna Children's Cancer Research Institute, Vienna, Austria; and.
  • Abagnale G; St. Anna Children's Cancer Research Institute, Vienna, Austria; and.
  • Attarbaschi A; St. Anna Children's Cancer Research Institute, Vienna, Austria; and.
  • Minkov M; St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
  • Halbritter F; St. Anna Children's Cancer Research Institute, Vienna, Austria; and.
  • Hutter C; Klinik Floridsdorf, Department of Pediatrics, Neonatology and Adolescent Medicine, Vienna, Austria.
Blood Adv ; 6(3): 970-975, 2022 02 08.
Article em En | MEDLINE | ID: mdl-34619771

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Histiocitose de Células de Langerhans / Proteínas Proto-Oncogênicas B-raf Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Áustria

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Histiocitose de Células de Langerhans / Proteínas Proto-Oncogênicas B-raf Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Áustria